2003
DOI: 10.1124/jpet.102.047522
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo

Abstract: Accumulating evidence suggests that enhanced peroxidative damage caused by reactive oxygen species (ROS) may contribute to the pathogenesis of cisplatin-induced acute renal failure. Nevertheless, little is known about the involvement of oxygen radicals in cisplatin nephropathy. In this study, we investigated the effects of a novel free radical scavenger, 3-methyl-1-phenyl-pyrazolin-5-one (MCI-186; edarabone), on murine proximal tubular cell (PTC) damage induced by exposure to cisplatin in vitro and on renal fu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
107
0
2

Year Published

2006
2006
2015
2015

Publication Types

Select...
6
2

Relationship

4
4

Authors

Journals

citations
Cited by 138 publications
(116 citation statements)
references
References 34 publications
5
107
0
2
Order By: Relevance
“…Moreover, edaravone reduced mitochondrial damage in homogenate made from ischemic-incubated rat brain (Watanabe et al 1994). As compared with other antioxidants, edaravone has the following advantages: (1) it has already been used in clinical practice mostly without the presence of serious side effects at the dose currently applied (Sueishi et al 2002); (2) it is lipophilic, and therefore, readily accessible to tissues (Satoh et al 2003); (3) it preferentially accumulates in the kidneys (Spitz et al 2011). This accumulation in the kidneys is desirable because it presumably confers some selectivity towards the healthy tissue and favors nephroprotection.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, edaravone reduced mitochondrial damage in homogenate made from ischemic-incubated rat brain (Watanabe et al 1994). As compared with other antioxidants, edaravone has the following advantages: (1) it has already been used in clinical practice mostly without the presence of serious side effects at the dose currently applied (Sueishi et al 2002); (2) it is lipophilic, and therefore, readily accessible to tissues (Satoh et al 2003); (3) it preferentially accumulates in the kidneys (Spitz et al 2011). This accumulation in the kidneys is desirable because it presumably confers some selectivity towards the healthy tissue and favors nephroprotection.…”
Section: Discussionmentioning
confidence: 99%
“…Cytochrome c oxidase is a large transmembrane protein that acts as a terminal acceptor in the electron transport chain. It is one of the key enzymes modulating mitochondrial functions, and its activity was assessed by enzyme histochemical method (8). Strong cytochrome c oxidase activity (brown) was observed to be widely expressed in the renal cortex, mainly in the tubular epithelium, in control group of mice (Fig.…”
Section: Amelioration Of Renal Injury and Extended Life Span By Klothmentioning
confidence: 99%
“…8. Semiquantitative analysis was performed by viewing random areas at a magnification of ϫ100 and scored for the number of apoptotic nuclei present in renal tissues.…”
Section: Assessment Of Apoptosismentioning
confidence: 99%
See 1 more Smart Citation
“…11 The percent positive area was measured with a color image analyzer. A total of 20 consecutive fields from each kidney were evaluated randomly at a magnification of  100.…”
Section: Cytochrome C Oxidase (Cox) Stainingmentioning
confidence: 99%